Cargando…

Impaired Fasting Glucose Is the Major Determinant of the 20‐Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease

BACKGROUND: We wanted to explore the association of metabolic syndrome (MetS) versus its individual components with 20‐year all‐cause mortality among patients with stable coronary artery disease. METHODS AND RESULTS: The cohort comprised 12 403 nondiabetic patients with stable coronary artery diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Younis, Arwa, Goldkorn, Ronen, Goldenberg, Ilan, Geva, Diklah, Tzur, Boaz, Mazu, Anna, Younis, Anan, Fisman, Zvi, Tannenbaum, Alexander, Klempfner, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721758/ https://www.ncbi.nlm.nih.gov/pubmed/29079562 http://dx.doi.org/10.1161/JAHA.117.006609

Ejemplares similares

Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
por: Younis, Arwa, et al.
Publicado: (2016)

The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
por: Younis, Arwa, et al.
Publicado: (2017)

Ethnic Disparity in Mortality Among Ischemic Heart Disease Patients. A-20 Years Outcome Study From Israel
por: Abu-Much, Arsalan, et al.
Publicado: (2021)

Heart Rate Variability for Risk Assessment of Myocardial Ischemia in Patients Without Known Coronary Artery Disease: The HRV‐DETECT (Heart Rate Variability for the Detection of Myocardial Ischemia) Study
por: Goldenberg, Ilan, et al.
Publicado: (2019)

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
por: Arbel, Yaron, et al.
Publicado: (2016)

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
por: Klempfner, Robert, et al.
Publicado: (2012)

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy
por: Younis, Arwa, et al.
Publicado: (2021)

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Ethnic disparity in Israel impacts long-term results after heart transplantation
por: Peled, Yael, et al.
Publicado: (2019)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults
por: Karve, Amrita, et al.
Publicado: (2010)

Thrombocytopenia and thrombocytosis are associated with different outcome in atrial fibrillation patients on anticoagulant therapy
por: Michowitz, Yoav, et al.
Publicado: (2019)

Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
por: Valentino, Giovanna, et al.
Publicado: (2015)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke
por: Riordan, Michael, et al.
Publicado: (2020)

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
por: Tenenbaum, Alexander, et al.
Publicado: (2014)

Elevation in systolic blood pressure during heart failure hospitalization is associated with increased short and long-term mortality
por: Segal, Omer, et al.
Publicado: (2017)

Low ALT blood levels are associated with lower baseline fitness amongst participants of a cardiac rehabilitation program
por: Kogan, Michael, et al.
Publicado: (2018)

Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study
por: Perelshtein Brezinov, Olga, et al.
Publicado: (2017)

Carotid Intima Media Thickness in Nondiabetic Hypertensive Nigerians: Role of Fasting and Postprandial Blood Glucose
por: Okeahialam, B. N., et al.
Publicado: (2016)

The Association between Mediterranean Diet and the Risk of Falls and Physical Function Indices in Older Type 2 Diabetic People Varies by Age
por: Tepper, Sigal, et al.
Publicado: (2018)

Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects
por: Milwidsky, Assi, et al.
Publicado: (2015)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

Nonlinear association between changes in fasting plasma glucose and the incidence of diabetes in a nondiabetic Chinese cohort
por: Huang, Chenghu, et al.
Publicado: (2022)

Low fasting serum insulin and dementia in nondiabetic women followed for 34 years
por: Mehlig, Kirsten, et al.
Publicado: (2018)

Bi-stable resistive switching characteristics in Ti-doped ZnO thin films
por: Younis, Adnan, et al.
Publicado: (2013)

Vitamin D Status and Quality of Life in Healthy Male High-Tech Employees
por: Tepper, Sigal, et al.
Publicado: (2016)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

The “Lipid Accumulation Product” Is Associated with 2-Hour Postload Glucose Outcomes in Overweight/Obese Subjects with Nondiabetic Fasting Glucose
por: Malavazos, Alexis Elias, et al.
Publicado: (2015)

Declining β-Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children
por: Tfayli, Hala, et al.
Publicado: (2010)

Fasting and 2-Hour Plasma Glucose and Insulin: Relationship with risk factors for cardiovascular disease in overweight nondiabetic children
por: Libman, Ingrid M., et al.
Publicado: (2010)

Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults
por: Patel, Nileshkumar, et al.
Publicado: (2012)

Community Resilience throughout the Lifespan – The Potential Contribution of Healthy Elders
por: Cohen, Odeya, et al.
Publicado: (2016)

Early post-stress decrease in cardiac performance by impedance cardiography and its relationship to the severity and extent of ischemia by myocardial perfusion imaging
por: Goldkorn, Ronen, et al.
Publicado: (2020)

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator
por: Younis, Arwa, et al.
Publicado: (2020)

On the Path to Thermo-Stable Collagen: Culturing the Versatile Sponge Chondrosia reniformis
por: Orel, Boaz, et al.
Publicado: (2021)

Vomiting and Dysphagia Predict Delayed Gastric Emptying in Diabetic and Nondiabetic Subjects
por: Boltin, Doron, et al.
Publicado: (2014)

Serial Coronary Imaging of Early Atherosclerosis Development in Fast-Food-Fed Diabetic and Nondiabetic Swine
por: van Ditzhuijzen, Nienke S., et al.
Publicado: (2016)

Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver
por: Lattuada, Guido, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lj01m2kqe1jfog03jcamgalght